REAL-WORLD INCIDENCE AND MANAGEMENT OF OCULAR HYPERTENSION AFTER SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE INJECTION FOR MACULAR EDEMA IN NONINFECTIOUS UVEITIS
In this real-world cohort, SCS-TA was associated with a low-incidence of OHT, consistent with clinical trial data. A history of glaucoma or OHT is a significant association for developing OHT after SCS-TA.
Authors
- Jordan D. Deaner (ORCID: https://orcid.org/0000-0002-3899-4456)
- Sunir J. Garg (ORCID: https://orcid.org/0000-0002-9115-6080)
- Jason Hsu (ORCID: https://orcid.org/0000-0002-2761-4219)
- James P. Dunn
- Yoshihiro Yonekawa (ORCID: https://orcid.org/0000-0002-6847-7169)
- Sidra Zafar (ORCID: https://orcid.org/0000-0002-9179-2837)
- Michael A. Klufas (ORCID: https://orcid.org/0000-0001-9539-7837)
- Ajay E. Kuriyan (ORCID: https://orcid.org/0000-0002-2824-3245)
- Saif Hamdan (ORCID: https://orcid.org/0000-0001-5636-4186)
- Michael N. Cohen (ORCID: https://orcid.org/0000-0002-9125-0499)
- David Xu (ORCID: https://orcid.org/0000-0003-3649-4746)
- Carl D. Regillo (ORCID: https://orcid.org/0000-0001-8260-9925)
- Jamie A Nassur
Institutions
- Thomas Jefferson University (US)
- Jack Miller Center (US)
- Wills Eye Hospital (US)
Publication Details
- Journal
- Retina
- Published
- 2025-09-15
- DOI
- https://doi.org/10.1097/iae.0000000000004677
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00